| Alimentiv, Inc. | |
| Type: | Public |
| Key People: | Pierre Gaudreault (CEO) |
| Predecessor: | Robarts Research Institute |
| Founded: | in London, Ontario, Canada |
| Industry: | Clinical Research |
| Area Served: | Worldwide |
Alimentiv Inc. is a contract research organization (CRO) specializing in GI clinical trials, medical imaging, precision medicine,[1] statistics services,[2] and clinical consulting for pharmaceutical and biotechnology companies.[3]
Headquartered in London, Ontario, Alimentiv employs more than 700 people across its operations in Canada, the United States, Europe, Asia-Pacific, and Latin America.[4]
Alimentiv operated as Robarts Clinical Trials, part of Western University starting in 1986.[5] In 2020 the company was purchased from Western University and began operations as Alimentiv Inc., the rebranding supposedly reflected the company’s continued growth as a specialized contract research organization. [6]
Today, Alimentiv provides services in more than 64 countries worldwide, collaborates with leading scientists and organizations around the globe such as Summit Clinical Research, LLC,[7] and works with pharmaceutical and biotechnology organizations to bring new and improved GI treatment options to patients.[8]
In 2021, Alimentiv acquired McDougall Scientific Ltd., a niche CRO specializing in statistical analysis, data management, reporting, and clinical trial design.[9] This was followed by Alimentiv launching AcelaBio in 2021, a commercial research laboratory, located in San Diego, CA delivering histopathology and precision medicine services for global clinical trials.[10]